Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Hcv Hepatitis'

Hcv Hepatitis published presentations and documents on DocSlides.

HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC

HCV cure by IFN-free DAAs is associated with increased survival in patients with HCV-related HCC

  • jovita
  • 18 Slides

Hansen Dang,. 1,2*. Yee Hui Yeo,. 1*. Satoshi Ya...

HCV Assays: Impact on HCV Studies

HCV Assays: Impact on HCV Studies

  • blanko
  • 14 Slides

& . Update on HCV . blood bank protocol. . Ov...

Future HCV Treatment Paradigms

Future HCV Treatment Paradigms

  • kittie-lecroy
  • 48 Slides

Mark Sulkowski, MD . Professor of Medicine. Medic...

Update on the HCV Antiviral Pipeline

Update on the HCV Antiviral Pipeline

  • natalia-silvester
  • 14 Slides

Todd S. Wills, MD. SPNS HCV Treatment Expansion I...

Treatment with the second-generation HCV protease inhibitor

Treatment with the second-generation HCV protease inhibitor

  • conchita-marotz
  • 20 Slides

Results from SILEN-C1 in HCV genotype-1 treatment...

Management of HCV in Co-Infected Patients

Management of HCV in Co-Infected Patients

  • danika-pritchard
  • 22 Slides

Marie-Louise Vachon, MD, . MSc. Division of . Inf...

Role of harm reduction in HCV prevention in France: from r

Role of harm reduction in HCV prevention in France: from r

  • tatiana-dople
  • 14 Slides

Bruno Spire & Patrizia Carrieri. How to reduc...

Sofosbuvir + Ribavirin in HCV Genotype 1

Sofosbuvir + Ribavirin in HCV Genotype 1

  • pamella-moone
  • 9 Slides

NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...

Sofosbuvir in HCV-

Sofosbuvir in HCV-

  • mitsue-stanley
  • 7 Slides

HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...

Access to antiviral drugs for treating HCV for HIV-positive

Access to antiviral drugs for treating HCV for HIV-positive

  • yoshiko-marsland
  • 12 Slides

AIDS 2016 | 18-22 July 2016 | Durban, South A...

Housing Choice Voucher Program

Housing Choice Voucher Program

  • phoebe-click
  • 21 Slides

LANDLORD BRIEFING. 2015. KHRA & HCV ~ Overvie...

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6

  • pasty-toler
  • 0 Slides

ASTRAL-1. Phase 3. . Treatment. . Naïve & ...

Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6

Elbasvir-Grazoprevir in Treatment-Naïve HCV Genotype 1, 4 or 6

  • celsa-spraggs
  • 0 Slides

C-EDGE Treatment Naïve (TN). Phase 3. . Treatme...

An Overview of HIV and HCV in Adolescents and Young Adults

An Overview of HIV and HCV in Adolescents and Young Adults

  • pamella-moone
  • 0 Slides

Cathryn. L. Samples, MD, MPH, AAHIVS. Director, ...

O nline census of drug consumption rooms as a setting to address HCV:

O nline census of drug consumption rooms as a setting to address HCV:

  • phoebe-click
  • 0 Slides

 . current practice and future capacity.. Vendul...

Simplified HCV Therapy in 2018

Simplified HCV Therapy in 2018

  • phoebe-click
  • 0 Slides

This program is s. upported. by educational gran...

Care of the Treatment-naive Patient With HCV/HIV Coinfection

Care of the Treatment-naive Patient With HCV/HIV Coinfection

  • cheryl-pisano
  • 0 Slides

. Case. 47-Year-Old . Man With Asymptomatic HIV ...

Effects of HIV/HCV coinfection on Bone Mineral Density and Structure

Effects of HIV/HCV coinfection on Bone Mineral Density and Structure

  • min-jolicoeur
  • 0 Slides

Amber Wheeler, MD. WIHS Scientific Meeting. June ...

Prevention strategies for HIV/HCV co infection

Prevention strategies for HIV/HCV co infection

  • giovanna-bartolotta
  • 0 Slides

Isabelle Andrieux-Meyer, MD. Médecins Sans Front...

INTEGRATING HIV AND HCV TESTING

INTEGRATING HIV AND HCV TESTING

  • cheryl-pisano
  • 0 Slides

30. 40. 50. 60. 70. 80. 90. 1. 00. 0 . 1. 0. . 2...

Is it possible? HCV Elimination

Is it possible? HCV Elimination

  • yoshiko-marsland
  • 0 Slides

Objectives. Define elimination as it relates to i...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

  • danika-pritchard
  • 0 Slides

IAPAC African Regional Capacity-Building Hub. Bas...

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1

  • danika-pritchard
  • 0 Slides

NIAID Retreatment. Phase . 2a . Treatment. . Exp...

HCV Clinical Management TRAINER(S)

HCV Clinical Management TRAINER(S)

  • trish-goza
  • 0 Slides

IAPAC African Regional Capacity-Building Hub. Bas...

OraQuick HCV Rapid Test

OraQuick HCV Rapid Test

  • sherrill-nordquist
  • 0 Slides

How to Run the . Test . Overview. Background Pres...

Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence

Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence

  • briana-ranney
  • 11 Slides

Sofosbuvir + Ribavirin to Prevent Post-Transplan...

Use of HCV DAAs with HIV Regimens

Use of HCV DAAs with HIV Regimens

  • robaut
  • 13 Slides

Sam Lam, . PharmD. Annie Vong, . PharmD. 2/3/2017....

Treatment of Chronic HCV

Treatment of Chronic HCV

  • lam
  • 58 Slides

with Direct-Acting Antivirals (DAAs). www.hcvguide...

HIV-HCV Coinfection in the era of effective antiviral therapy

HIV-HCV Coinfection in the era of effective antiviral therapy

  • mia
  • 21 Slides

Mark Sulkowski, . MD. Professor of Medicine. Medic...

Economic Impact of Eliminating HCV

Economic Impact of Eliminating HCV

  • InLoveWithLife
  • 11 Slides

H. . Razavi. April 13, 2016. HCV Economic impact m...

Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Thro

Align OPTN Policies with the 2013 PHS Guideline for Reducing Transmission of HIV, HBV, and HCV Thro

  • SoulfulDreamer
  • 26 Slides

(Resolution 13). Ad Hoc Disease Transmission Advis...

Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA

Challenge and Opportunity for HCV Elimination among Young PWID in New York City: Relatively Low RNA

  • WannabeRockstar
  • 10 Slides

seroconversion. and genetically linked HCV infect...

Aptima HCV RNA Qualitative Assay

Aptima HCV RNA Qualitative Assay

  • delilah
  • 34 Slides

Aptima HCV RNA Qualitative Assay1 500237 Rev. 003 ...

Abbott RealTime HCV Genotype II PMA CONFIDENTIAL

Abbott RealTime HCV Genotype II PMA CONFIDENTIAL

  • desha
  • 30 Slides

mHCV Genotype II Key to symbols used Global Tra...

EASL 2019 HCV Conference Update

EASL 2019 HCV Conference Update

  • sophia
  • 54 Slides

April 10. –14. , 2019. Vienna, Austria. Disclaim...

Sofosbuvir + Ribavirin in HCV Recurrence

Sofosbuvir + Ribavirin in HCV Recurrence

  • williams
  • 8 Slides

Following Liver Transplantation. Phase 2. Charlton...

NITCAR HCV Audit Chloe Eaton, Suzie English, Ben Warne

NITCAR HCV Audit Chloe Eaton, Suzie English, Ben Warne

  • candy
  • 7 Slides

Supervising Consultant: Dr K. . Rolfe. Update: Mar...

HIV & HCV through the Medicine Wheel

HIV & HCV through the Medicine Wheel

  • winnie
  • 47 Slides

Our Services. Emotional:. Reactions. Feelings abou...

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis

Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis

  • ahmir
  • 11 Slides

ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...

HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*

HAS THERE EVER BEEN A NATIONAL ESTIMATE OF HCV PREVALENCE IN THE GENERAL POPULATION FROM A ROBUST*

  • jesse588
  • 1 Slides

Mandatory criteria: . Probability based sampling. ...

Copyright © 2024 DocSlides. All Rights Reserved